JOHN KEEFE: Open Payments
NPI 1548268881 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 20 payments from 11 companies in 2025. Trend: 2023 $217 · 2024 $470 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $115 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| ABIOMED | 1 | $31 |
| PFIZER INC. | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Amgen Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: CARDIOMEMS, JARDIANCE, CAMZYOS, LEQVIO, ELIQUIS, FUROSCIX, Repatha, CAPVAXIVE.
Industry payments across NY — which companies pay providers there.
